west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "ZHONG Xiaorong" 3 results
  • New follow-up management model of “Breast Cancer Information Management System” during coronavirus disease 2019 epidemic

    During the coronavirus disease 2019 epidemic, West China Hospital, Sichuan University explored a new management model to ensure timely diagnosis and treatment and regular follow-up for breast cancer patients. On the basis of previous internet Breast Cancer Information Management System, patient management WeChat groups were integrated to develop an online and offline interconnect management platform. Regular follow-up of patients was mainly conducted by telephone, with WeChat management group as auxiliary. Coronavirus infections were screened during telephone follow-up. In the meanwhile, patients who needed to be further treated would be identified and recommended to the outpatient follow-up. The new management model can improve the efficiency of follow-up management, on the premise of reducing the risk of coronavirus disease 2019 transmission for both health care providers and patients.

    Release date:2020-10-26 03:00 Export PDF Favorites Scan
  • Screening and expression verification of key genes in hepatocellular carcinoma by bioinformatics analysis

    ObjectiveTo explore the clinical significance and possible potential mechanism of hepatocellular carcinoma through the screening of key genes in hepatocellular carcinoma.MethodsHepatocellular carcinoma gene chip was obtained from GEO database, differentially expressed genes (DEGs) were screened by GEO2R online tools and Venn map, GO analysis and KEGG pathway analysis were performed in DAVID database, core genes were screened by STRING and Cytscape software, core genes were analyzed in Kaplan-Meier Plotter for survival analysis, and expression was analyzed by GEPIA database. The core genes related to prognosis and highly expressed in hepatocellular carcinoma were analyzed by Metascape online tool for function and pathway enrichment analysis. Finally, the key genes were verified in hepatocellular carcinoma and paracancerous tissues.ResultsA total of 94 DEGs were screened from three gene chips GSE14520, GSE60502, and GSE102079, obtained from GEO. After the selected DEGs was analyzed by GO function analysis, KEGG pathway enrichment analysis, STRING and Cytscape software by DAVID, 19 core DEGs were screened. After 19 core DEGs were analyzed by Kaplan-Meier Plotter website, 9 genes [ribonucleotide reductase M2 (RRM2), polycomb repressive complex 1 (PRC1), topoisomerase Ⅱ alpha (TOP2A), aurora kinase A (AURKA), nucleolar spindle-associated protein 1 (NUSAP1), Rac-GTPase activating protein 1 (RACGAP1), abnormal spindle-like microcephaly-associated (ASPM), cyclin dependent kinase 1 (CDK1) and GINS complex subunit 1 (GINS1)] were found to be associated with the prognosis of hepatocellular carcinoma. The expressions of these 9 genes were analyzed by GEPIA, and the results showed that all 9 genes were highly expressed in hepatocellular carcinoma tissues. The functions and pathways of 9 highly expressed genes were analyzed by metascape website. Finally, RRM2 was selected for verification in hepatocellular carcinoma tissues and adjacent tissues, and it was found that the staining score of RRM2 in hepatocellular carcinoma tissues was (10.9±1.5) points, which was significantly higher than its staining score in adjacent tissues [(4.5±1.2) points], P<0.001.ConclusionThe nine genes identified by bioinformatics analysis may be the key genes in the occurrence and development of hepatocellular carcinoma, which can provide reference for further study on the pathogenesis, diagnosis and treatment of hepatocellular carcinoma.

    Release date:2021-06-24 04:18 Export PDF Favorites Scan
  • Development of a prediction model of absolute risk for breast cancer

    ObjectivesTo explore the construction method of prediction model of absolute risk for breast cancer and provide personalized breast cancer management strategies based on the results.MethodsA case-control design was conducted with 2 747 individuals diagnosed as primary breast cancer by pathology in West China Hospital of Sichuan University from 2000 to 2017 and 6 307 healthy controls from Breast Cancer Screening Cohort in Sichuan Women and Children Center and Chengdu Shuangliu District Maternal and Child Health Hospital. Standardized questionnaires and information management systems in hospital were used to collect information. Decision trees, logistic regression, the formula in Gail model and registration data in China were used to estimate the probability of 5-year risk of breast cancer. Eventually a ROC (receiver operating characteristics) curve was drawn to identify optimal cut-off value, and the power was evaluated.ResultsThe decision tree exported 4 variables, which were urban or rural sources, number of live birth, age and age at menarche. The median 5-year risk and interquartile range of the controls was 0.027% and 0.137%, while the median 5-year risk and interquartile range of the cases was 0.219% and 0.256%. The ROC curve showed the cut-off value was 0.100%. Through verification, the sensitivity was 0.79, the specificity was 0.73, the accuracy was 0.75, and the AUC (area under the curve) was 0.79.ConclusionsThe methods used in our study based on 9 054 female individuals in Sichuan province could be used to predict the 5-year risk for breast cancer. Predictor variables include urban or rural sources, number of live birth, age, and age at menarche. If the 5-year risk is more than 0.100%, the person will be judged as a high risk individual.

    Release date:2020-01-14 05:25 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content